Heart disease is the leading cause of death in Type 1 diabetic patients, however the mechanistic link has not been fully established. In this study an inducible and reversible mouse model of Type 1 diabetes was used. Depression of cardiac function and the increase in blood glucose occur in combination with suppression of pyruvate to bicarbonate conversion. By reversing diabetes with Glibenclamide, cardiac function and blood glucose concentration was restored. This study demonstrated changes that occur alongside the development of a reversible model of Type 1 diabetes and how the action of Glibenclamide can affect metabolism and function of the heart.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords